Skip to main content
. 2021 May 14;12:666022. doi: 10.3389/fimmu.2021.666022

Figure 1.

Figure 1

(A) Comparison of serum BAFF levels between healthy donors and pemphigus patients at baseline. (B) Comparison of baseline serum BAFF levels between short-term relapsing patients and non-relapsing patients. Blue circles represent rituximab-treated patients. Red squares represent corticosteroids-treated patients. *p < 0.05.